Genome-wide search for genetic modulators in gene regulatory pathways: weighted window-based peak identification
Eunjee Lee1, Kyunga Kim, Taesung Park
1Interdisciplinary Program in Bioinformatics, Seoul National University, Republic of Korea. eunjee01@gmail.com
Genomics
|March 23, 2011
Summary
This study introduces a new two-step method to identify genetic modulators influencing multiple genes in biological pathways. The approach enhances the understanding of gene transcription regulation beyond single-gene expression quantitative trait loci (eQTL) analysis.
Area of Science:
- Genetics
- Molecular Biology
- Bioinformatics
Background:
- Expression quantitative trait loci (eQTL) studies analyze genome-wide gene expression and genotype data to understand gene transcription genetics.
- Current eQTL analyses primarily focus on single-gene expression levels, potentially limiting the explanation of complex gene regulatory pathways involving multiple genes and modulators.
Purpose of the Study:
- To develop and illustrate a novel two-step method for identifying genetic modulators of transcription processes affecting multiple genes within biological pathways.
- To improve the detection of genetic modulators for both individual genes and master regulators of multiple genes.
Main Methods:
- A two-step approach was developed, incorporating a weighted window-based peak identification algorithm for individual gene modulator detection.
- A Poisson-based test was employed to identify master genetic modulators influencing multiple genes simultaneously.
- The method was applied to analyze gene expression and single nucleotide polymorphism (SNP) chip data from Centre d'Etude du Polymorphisme Humain (CEPH) lymphoblast cells.
Main Results:
- The novel method successfully identified potential genetic modulators of transcription for multiple genes.
- The weighted window-based algorithm improved the detection of genetic modulators for individual genes.
- The Poisson-based test effectively identified master genetic modulators within biological pathways.
Conclusions:
- The developed two-step method offers a more comprehensive approach to understanding the genetic regulation of gene transcription pathways.
- This method advances eQTL analysis by considering multi-gene regulatory networks, providing deeper insights into complex biological processes.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...